OrthoPediatrics Corp
KIDS20.560USD
+0.170+0.83%
Market hours （ET）Quotes delayed by 15 min
510.46MMarket Cap
LossP/E TTM
More Details of OrthoPediatrics Corp Company
OrthoPediatrics Corp. is an orthopedic company, which is focused on advancing the field of pediatric orthopedics. The Company is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. It markets 53 surgical and specialized bracing systems.
Company Info
Ticker SymbolKIDS
Company nameOrthoPediatrics Corp
IPO dateOct 12, 2017
CEOMr. David R. Bailey
Number of employees562
Security typeOrdinary Share
Fiscal year-endOct 12
Address2850 Frontier Drive
CityWARSAW
Stock exchangeNASDAQ Global Market Consolidated
CountryUnited States of America
Postal code46582
Phone15742686379
Websitehttps://www.orthopediatrics.com/
Ticker SymbolKIDS
IPO dateOct 12, 2017
CEOMr. David R. Bailey
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. David R. Bailey
Mr. David R. Bailey
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
319.15K
+39.81%
Mr. Fred L. Hite
Mr. Fred L. Hite
Chief Financial Officer, Chief Operating Officer, Director
Chief Financial Officer, Chief Operating Officer, Director
207.99K
+37.66%
Mr. Mark C. Throdahl
Mr. Mark C. Throdahl
Chairman of the Board
Chairman of the Board
190.38K
+4.62%
Mr. Gregory A. Odle
Mr. Gregory A. Odle
President of Scoliosis
President of Scoliosis
148.79K
+28.96%
Mr. Joseph W. Hauser
Mr. Joseph W. Hauser
President of Trauma, Deformity and OPSB
President of Trauma, Deformity and OPSB
137.66K
+51.62%
Mr. David R. Pelizzon
Mr. David R. Pelizzon
Independent Director
Independent Director
32.95K
+34.22%
Mr. Bryan W. Hughes
Mr. Bryan W. Hughes
Independent Director
Independent Director
21.23K
+65.50%
Mr. Samuel D. Riccitelli
Mr. Samuel D. Riccitelli
Independent Director
Independent Director
20.42K
+69.88%
Ms. Marie C. Infante, J.D.
Ms. Marie C. Infante, J.D.
Independent Director
Independent Director
19.77K
+73.92%
Mr. Terry D. Schlotterback
Mr. Terry D. Schlotterback
Lead Independent Director
Lead Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. David R. Bailey
Mr. David R. Bailey
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
319.15K
+39.81%
Mr. Fred L. Hite
Mr. Fred L. Hite
Chief Financial Officer, Chief Operating Officer, Director
Chief Financial Officer, Chief Operating Officer, Director
207.99K
+37.66%
Mr. Mark C. Throdahl
Mr. Mark C. Throdahl
Chairman of the Board
Chairman of the Board
190.38K
+4.62%
Mr. Gregory A. Odle
Mr. Gregory A. Odle
President of Scoliosis
President of Scoliosis
148.79K
+28.96%
Mr. Joseph W. Hauser
Mr. Joseph W. Hauser
President of Trauma, Deformity and OPSB
President of Trauma, Deformity and OPSB
137.66K
+51.62%
Mr. David R. Pelizzon
Mr. David R. Pelizzon
Independent Director
Independent Director
32.95K
+34.22%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Trauma and Deformity
37.87M
72.25%
Scoliosis
13.66M
26.07%
Sports Medicine and Other
880.00K
1.68%
By RegionUSD
Name
Revenue
Proportion
U.S.
40.89M
78.02%
International
11.52M
21.98%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Trauma and Deformity
37.87M
72.25%
Scoliosis
13.66M
26.07%
Sports Medicine and Other
880.00K
1.68%
Shareholding Stats
Updated: Fri, Jul 11
Updated: Fri, Jul 11
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Squadron Capital LLC
27.86%
Brown Capital Management, LLC
6.74%
Brown Advisory
6.58%
BlackRock Institutional Trust Company, N.A.
4.61%
Braidwell LP
4.47%
Other
49.73%
Shareholders
Shareholders
Proportion
Squadron Capital LLC
27.86%
Brown Capital Management, LLC
6.74%
Brown Advisory
6.58%
BlackRock Institutional Trust Company, N.A.
4.61%
Braidwell LP
4.47%
Other
49.73%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
31.07%
Corporation
27.86%
Investment Advisor
27.72%
Hedge Fund
8.13%
Individual Investor
5.23%
Research Firm
2.78%
Pension Fund
1.90%
Bank and Trust
0.22%
Insurance Company
0.02%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
306
26.02M
105.03%
-1.04M
2025Q1
321
26.03M
105.09%
-1.19M
2024Q4
319
25.60M
105.70%
-1.27M
2024Q3
325
25.26M
104.34%
-2.01M
2024Q2
325
25.18M
104.01%
-1.27M
2024Q1
329
24.43M
104.11%
-1.85M
2023Q4
333
24.59M
105.32%
-1.43M
2023Q3
324
24.49M
104.97%
-1.38M
2023Q2
326
24.28M
104.23%
-1.82M
2023Q1
322
24.51M
106.85%
-205.69K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Squadron Capital LLC
6.90M
27.86%
--
--
Mar 28, 2025
Brown Capital Management, LLC
1.67M
6.74%
-211.88K
-11.26%
Mar 31, 2025
Brown Advisory
1.63M
6.58%
+94.72K
+6.17%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.14M
4.61%
+11.85K
+1.05%
Mar 31, 2025
Braidwell LP
1.11M
4.47%
--
--
Mar 31, 2025
Wellington Management Company, LLP
1.05M
4.26%
-6.76K
-0.64%
Mar 31, 2025
The Vanguard Group, Inc.
932.48K
3.76%
+14.08K
+1.53%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
749.36K
3.03%
+77.39K
+11.52%
Mar 31, 2025
Wasatch Global Investors Inc
717.88K
2.9%
+21.56K
+3.10%
Mar 31, 2025
Granahan Investment Management, LLC
667.06K
2.69%
-119.31K
-15.17%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
Invesco NASDAQ Future Gen 200 ETF
0.49%
SPDR S&P Health Care Equipment ETF
0.42%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.12%
iShares Micro-Cap ETF
0.08%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.04%
Avantis US Small Cap Equity ETF
0.04%
WisdomTree US SmallCap Fund
0.03%
iShares Russell 2000 Value ETF
0.02%
ProShares UltraPro Russell2000
0.01%
DFA Dimensional US Small Cap Value ETF
0.01%
View more
Invesco NASDAQ Future Gen 200 ETF
Proportion0.49%
SPDR S&P Health Care Equipment ETF
Proportion0.42%
SPDR SSGA US Small Cap Low Volatility Index ETF
Proportion0.12%
iShares Micro-Cap ETF
Proportion0.08%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.04%
Avantis US Small Cap Equity ETF
Proportion0.04%
WisdomTree US SmallCap Fund
Proportion0.03%
iShares Russell 2000 Value ETF
Proportion0.02%
ProShares UltraPro Russell2000
Proportion0.01%
DFA Dimensional US Small Cap Value ETF
Proportion0.01%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
